Zydus Cadila’s board has approved the transfer of Animal Healthcare Business (AHB) of the company, on a going concern basis, to its wholly owned subsidiary Zydus Animal Health and Investments (ZAHL) through execution of a Definitive Agreement.
AHB consists of the business of development, manufacturing, marketing and selling of Animal Healthcare products in India and other countries. The transfer of AHB to ZAHL is subject to satisfaction of certain conditions precedent as provided in the Definitive Agreement. The Board of Directors at its meeting held on March 11, 2020 has approved the same.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
